AQST FY 2020 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$46M-12.8% YoY

Gross Profit

$33M71.7% margin

Operating Income

-$43M-93.6% margin

Net Income

-$56M-121.7% margin

EPS (Diluted)

$-1.66

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$46M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$63M

Total Liabilities

$111M

Stockholders' Equity

-$48M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$46M	$53M	-12.8%
Gross Profit	$33M	$32M	+2.0%
Operating Income	-$43M	-$53M	+18.6%
Net Income	-$56M	-$66M	+15.8%